AAP - Fondation Wiskott-Aldrich (WAF)

Areas of interest: • New and innovative curative treatment approaches for X linked thrombocytopenia (XLT)/Wiskott-Aldrich Syndrome (WAS) with reduced mortality and morbidity. • Innovative methods to better existent curative treatments leading to less mortality, morbidity, and or improved correction of the disease.

Application Deadline: September 30, 2020.